Search research articles
Contact Us
Filters
Showing results (281-290 of 355) with videos related to
Page
of 36
Sort By:
Voprosy Onkologii
|
April 23, 2013
[Optimization of treatment methods of surgical complications in lung cancer]
A I Arsen'ev, A O Nefedov, E V Levchenko, et al.
Breast Cancer Research and Treatment
|
February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Blood Cancer Journal
|
April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients
Samilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
British Journal of Haematology
|
March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402
Brad S Kahl, Fangxin Hong, Michael E Williams, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Practical Radiation Oncology
|
November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
Leslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Cancer Medicine
|
March 25, 2026
Qualitative Study of Breast Cancer and Lymphoma Patients Participating in a Physical Activity Intervention: The Case for Tailored Physical Activity
Brianna N Leitzelar, Juliana V Costa, Aylin A Aguilar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Cancer
|
October 22, 2025
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments
John Devin Peipert, Shaili Ganatra, Fengmin Zhao, et al.
Page
of 36
Search research articles
Search
Showing results (281-290 of 355) with videos related to
Sort By:
Page
of 36
Voprosy Onkologii
|
April 23, 2013
[Optimization of treatment methods of surgical complications in lung cancer]
A I Arsen'ev, A O Nefedov, E V Levchenko, et al.
Breast Cancer Research and Treatment
|
February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Blood Cancer Journal
|
April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients
Samilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
British Journal of Haematology
|
March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402
Brad S Kahl, Fangxin Hong, Michael E Williams, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Practical Radiation Oncology
|
November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
Leslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Cancer Medicine
|
March 25, 2026
Qualitative Study of Breast Cancer and Lymphoma Patients Participating in a Physical Activity Intervention: The Case for Tailored Physical Activity
Brianna N Leitzelar, Juliana V Costa, Aylin A Aguilar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Cancer
|
October 22, 2025
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments
John Devin Peipert, Shaili Ganatra, Fengmin Zhao, et al.
Page
of 36